Investment in the team approach to enhance the Journal's impact.
作者信息
Chang Susan M
机构信息
Department of Neurological Surgery, University of California at San Francisco, San Francisco, California, USA.
出版信息
Neuro Oncol. 2025 Jan 12;27(1):1-2. doi: 10.1093/neuonc/noae265.
Abstract
摘要
相似文献
1
Investment in the team approach to enhance the Journal's impact.投资采用团队合作方式以提升该期刊的影响力。
Neuro Oncol. 2025 Jan 12;27(1):1-2. doi: 10.1093/neuonc/noae265.
2
3
The journal's first year of publication and the challenges ahead.期刊的创刊元年与未来挑战。
Isr J Health Policy Res. 2012 Dec 21;1(1):52. doi: 10.1186/2045-4015-1-52.
4
Mapping 60 Years of Psychophysiology: A Bibliometric Analysis of Journal Performance, Authorship Trends, and Thematic Evolution.绘制60年心理生理学图谱：期刊表现、作者趋势和主题演变的文献计量分析
Psychophysiology. 2025 Feb;62(2):e70002. doi: 10.1111/psyp.70002.
5
Methods in year 50: preserving the past and preparing for the future.50年的方法：保存过去，为未来做准备。
Methods Inf Med. 2011;50(1):1-6. doi: 10.3414/ME10-05-0005.
6
Interventions to prevent misconduct and promote integrity in research and publication.预防科研与出版领域不当行为并促进诚信的干预措施。
Cochrane Database Syst Rev. 2016 Apr 4;4(4):MR000038. doi: 10.1002/14651858.MR000038.pub2.
7
Effective Manuscript Preparation and Submission.有效稿件准备与提交
Clin Podiatr Med Surg. 2024 Apr;41(2):351-358. doi: 10.1016/j.cpm.2023.08.004. Epub 2023 Oct 12.
8
The impact of higher education investment on the urban-rural income gap: An analysis of mediating and threshold effects based on data from China's eight major comprehensive economic zones.高等教育投资对城乡收入差距的影响：基于中国八大综合经济区数据的中介效应与门槛效应分析
PLoS One. 2025 Jun 25;20(6):e0326059. doi: 10.1371/journal.pone.0326059. eCollection 2025.
9
Forty-five years of disability and rehabilitation research: review of the journal Disability and Rehabilitation through bibliometric analysis.45年的残疾与康复研究：通过文献计量分析对《残疾与康复》期刊的综述
Disabil Rehabil. 2025 Jun;47(11):2960-2974. doi: 10.1080/09638288.2024.2403731. Epub 2024 Sep 18.
10
A Systematic Review of Meta-analyses Published in Arthroscopy: The Journal of Arthroscopic and Related Surgery.发表于《关节镜检查：关节镜及相关外科杂志》的荟萃分析的系统评价
Arthroscopy. 2016 Mar;32(3):528-37. doi: 10.1016/j.arthro.2015.08.002. Epub 2015 Oct 4.
本文引用的文献
1
The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma.新型DNA交联剂KL-50对新发性和复发性替莫唑胺治疗后错配修复缺陷型胶质母细胞瘤的患者来源模型具有活性。
Neuro Oncol. 2025 Mar 7;27(3):644-651. doi: 10.1093/neuonc/noae257.
2
Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessments.可测量疾病作为胶质母细胞瘤疗效评估的基线标准：基于PET（PET RANO 1.0）和基于MRI（RANO）评估的比较
Neuro Oncol. 2025 Jan 12;27(1):77-88. doi: 10.1093/neuonc/noae208.
3
Neuroimmune-competent human brain organoid model of diffuse midline glioma.弥漫性中线胶质瘤的神经免疫活性人脑类器官模型
Neuro Oncol. 2025 Feb 10;27(2):369-382. doi: 10.1093/neuonc/noae245.
4
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses.异柠檬酸脱氢酶（IDH）野生型胶质母细胞瘤的纵向多模态分析揭示了预后不同的治疗反应背后的分子进化和细胞表型。
Neuro Oncol. 2025 Jan 12;27(1):89-105. doi: 10.1093/neuonc/noae214.
5
Point/Counterpoint: The role of reirradiation in recurrent glioblastoma.针锋相对：再程放疗在复发性胶质母细胞瘤中的作用
Neuro Oncol. 2025 Jan 12;27(1):7-12. doi: 10.1093/neuonc/noae209.
6
Intracranial administration of anti-PD-1 and anti-CTLA-4 immune checkpoint-blocking monoclonal antibodies in patients with recurrent high-grade glioma.对复发性高级别胶质瘤患者进行颅内给予抗程序性死亡受体1（anti-PD-1）和抗细胞毒性T淋巴细胞相关蛋白4（anti-CTLA-4）免疫检查点阻断单克隆抗体治疗。
Neuro Oncol. 2024 Dec 5;26(12):2208-2221. doi: 10.1093/neuonc/noae177.
7
cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas.cIMPACT-NOW更新8：脑膜瘤分子风险参数的澄清及世界卫生组织分级建议
Neuro Oncol. 2025 Feb 10;27(2):319-330. doi: 10.1093/neuonc/noae170.
Zotero 插件